Daiwa Adjusts Price Target on Morgan Stanley to $108 From $105, Maintains Neutral Rating

MT Newswires06:20 ET · Ratings

Daiwa: Maintains zoomlion 'In line with the market' rating with a target price of 5 Hong Kong dollars.

Morgan Stanley released a research report stating that the target price of Zoomlion (01157) has been raised from 3.9 Hong Kong dollars to 5 Hong Kong dollars, maintaining a 'synchronous with the broader market' rating. The report mentioned that the third-quarter sales of most mainland construction machinery companies met expectations, coupled with steady overseas profit growth and local losses narrowing, resulting in some improvements. However, caution is still maintained on mainland cyclical trends and ongoing destocking overseas in the fourth quarter, with differences in the operational aspects of individual companies. The bank stated a preference for jiangsu hengli hydraulic (601100.SH) and Zhejiang Dingli Machinery (603338.SH), with target prices of 63 RMB and 5 respectively.

Sina Hong Kong stocks03:06 ET

Daiwa: Lowered the target price of hsbc holdings to HK$76.8. Prefer stanchart.

Morgan Stanley released a research report stating that the target price of HSBC Holdings (00005) has been lowered from HK$78.4 to HK$76.8, with a 'shareholding' rating. HSBC, Standard Chartered (02888), and Bank of China Hong Kong (02388) will announce their performance in October and November respectively. Key factors will include the outlook for the 2025 fiscal year's net interest margin (NIM) and Standard Chartered's future capital return plans. Morgan Stanley also mentioned a preference for international banks over local banks. Overall, Standard Chartered is currently Morgan Stanley's top choice. The bank stated that lower quarterly average HIBOR and soft loan growth will result in a net ...

新浪港股03:04 ET

DBS: Maintains a "shareholding" rating on Stanchart Group, with target price raised to 103.2 Hong Kong dollars.

Morgan Stanley released a research report stating that the target price of Standard Chartered (02888) has been raised by 3.2%, from 100 Hong Kong dollars to 103.2 Hong Kong dollars, maintaining a "shareholding" rating. The bank's fundamental assumptions for the company include income growth after 2024, moderate net interest margin pressure, good cost control, and healthy crediting quality. JPMorgan indicated an upward adjustment of Standard Chartered's earnings per share forecasts for 2024, 2025, and 2026 by 2.6%, 0.9%, and 1.5%, respectively. Three-year net interest income (NII) forecasts have been lowered, reflecting lower-than-expected loan growth in 2024 and other factors. Adjustment in the forecast for non-NII for the next three years.

Sina Hong Kong stocks01:55 ET

Big Lenders Expected to Show Investment Banking Upswing -- Barrons.com

Barron's01:00 ET

Daiwa: Maintains wuxi apptec's target price of 50 Hong Kong dollars and a "shareholding" rating.

Morgan Stanley released a research report stating that, according to media reports last Thursday, in view of potential restrictions under the US Biosafety Law, WuXi AppTec (02359) is exploring the sale of its overseas facilities. The report stated that WuXi AppTec has sold its Cell and Gene Therapy (CGT) Advanced Therapy Manufacturing Department (ATU) located in Philadelphia. Maintaining a target price of HK$50 for WuXi AppTec (02359) and a "shareholding" rating. The report indicates that the recent focus of the US Biosafety Law is on restricting access to more genetic information. Given the direct risk faced by WuXi AppTec's ATU under the Biosafety Law, and from 2024.

Sina Hong Kong StocksOct 7 02:55 ET